Compare Novo Nordisk A/S (NVO) vs VICI Properties Inc (VICI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs VICI Properties Inc — how do they compare? Novo Nordisk A/S trades at $45.96 (market cap $207.85B), while VICI Properties Inc trades at $25.99 (market cap $28.61B). The key difference: Novo Nordisk A/S is far larger — about 7.3× VICI Properties Inc's market cap, and VICI Properties Inc pays the higher dividend (6.93%). Which is the better fit depends on your goals.
| NVO | VICI | |
|---|---|---|
Market Cap | $207.85B | $28.61B |
Sector | Health | Real Estate |
52-Week High | $63.98 | $33.78 |
52-Week Low | $35.29 | $25.94 |
Enterprise Value | $222.55B | $46.16B |
Dividend Yield | 3.81% | 6.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About VICI Properties Inc
VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →
